ALT This image is a promotional graphic featuring a person in professional attire. The text highlights a discussion about "GLUD1 / Glutamate dehydrogenase hyperinsulinism" and the phrase "48 hours that changed the case." It mentions Dr. Linda Genen, MD, MPH, who is identified as a neonatologist and Chief Medical Officer at GeneDx.

ALT A group of people sitting on a stage panel at the Breakthroughs26 event. A large screen on the left displays a person speaking. The background features purple lighting and the event's logo.

ALT A panel of three individuals sitting on stage at the "Breakthroughs 26" event. A background with the event name is visible. All are dressed in formal attire, engaged in discussion.

ALT A group of eight people sit on a stage, participating in a panel discussion. Behind them, a large screen displays the text "BREAKTHROUGHS26" with a stylized logo. The setting is professional, with a modern design and lighting. Audience members are visible in the foreground.

ALT Yellow background with "GeneDx" logo and handwritten word "News" with a pen illustration. Text reads: "Sunshine Genetics enrolls first Florida families, launching expanded newborn screening pilot program.

ALT A newborn sleeps peacefully, cradled in gentle hands. The background features text announcing that GeneDx will present new evidence advancing genomic newborn screening at ICoNS 2026.

ALT Flyer for the Children's Hospital Neonatal Consortium (CHNC) Conference, October 19-21, 2026, in Denver, Colorado. Text invites attendees to visit GeneDx for insights on genetic causes in critically ill infants, highlighting clinical evidence and management improvements for NICU patients. Includes decorative elements and a heart symbol.

ALT A small hand gripping a larger one is featured prominently. The top of the image has the GeneDx logo and the word “News.” Text reads: “Oregon to begin enrollment in nationwide newborn genomic screening research study.” The background is blue with a yellow abstract shape behind the hands.